Housand C - Search Results

1

Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study.

Dzierlenga MW, Moreau M, Song G, Mallick P, Ward PL, Campbell JL, Housand C, Yoon M, Allen BC, Clewell HJ 3rd, Longnecker MP. Dzierlenga MW, et al. Among authors: housand c. Environ Res. 2020 Mar;182:109017. doi: 10.1016/j.envres.2019.109017. Epub 2019 Dec 9. Environ Res. 2020. PMID: 31865168 Free article.

2

Towards translating in vitro measures of thyroid hormone system disruption to in vivo responses in the pregnant rat via a biologically based dose response (BBDR) model.

Fisher J, Housand C, Mattie D, Nong A, Moreau M, Gilbert M. Fisher J, et al. Among authors: housand c. Toxicol Appl Pharmacol. 2023 Nov 15;479:116733. doi: 10.1016/j.taap.2023.116733. Epub 2023 Oct 20. Toxicol Appl Pharmacol. 2023. PMID: 37866708

3

How Many Urine Samples Are Needed to Accurately Assess Exposure to Non-Persistent Chemicals? The Biomarker Reliability Assessment Tool (BRAT) for Scientists, Research Sponsors, and Risk Managers.

Verner MA, Salame H, Housand C, Birnbaum LS, Bouchard MF, Chevrier J, Aylward LL, Naiman DQ, LaKind JS. Verner MA, et al. Among authors: housand c. Int J Environ Res Public Health. 2020 Dec 6;17(23):9102. doi: 10.3390/ijerph17239102. Int J Environ Res Public Health. 2020. PMID: 33291237 Free PMC article.

4

Lifetime PCB 153 bioaccumulation and pharmacokinetics in pilot whales: Bayesian population PBPK modeling and Markov chain Monte Carlo simulations.

Weijs L, Roach AC, Yang RS, McDougall R, Lyons M, Housand C, Tibax D, Manning T, Chapman J, Edge K, Covaci A, Blust R. Weijs L, et al. Among authors: housand c. Chemosphere. 2014 Jan;94:91-6. doi: 10.1016/j.chemosphere.2013.09.019. Epub 2013 Sep 27. Chemosphere. 2014. PMID: 24080004

5

Quantitative systems toxicology.

Bloomingdale P, Housand C, Apgar JF, Millard BL, Mager DE, Burke JM, Shah DK. Bloomingdale P, et al. Among authors: housand c. Curr Opin Toxicol. 2017 Jun;4:79-87. doi: 10.1016/j.cotox.2017.07.003. Epub 2017 Aug 2. Curr Opin Toxicol. 2017. PMID: 29308440 Free PMC article.

6

Impact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of Treatment.

Bruno CD, Elmokadem A, Housand C, Jordie EB, Chow CR, Laughren TP, Greenblatt DJ. Bruno CD, et al. Among authors: housand c. J Clin Pharmacol. 2022 Jan;62(1):55-65. doi: 10.1002/jcph.1947. Epub 2021 Aug 26. J Clin Pharmacol. 2022. PMID: 34339048

7

Brexpiprazole Pharmacokinetics in CYP2D6 Poor Metabolizers: Using Physiologically Based Pharmacokinetic Modeling to Optimize Time to Effective Concentrations.

Elmokadem A, Bruno CD, Housand C, Jordie EB, Chow CR, Lesko LJ, Greenblatt DJ. Elmokadem A, et al. Among authors: housand c. J Clin Pharmacol. 2022 Jan;62(1):66-75. doi: 10.1002/jcph.1946. Epub 2021 Aug 26. J Clin Pharmacol. 2022. PMID: 34328221

8

A multi-route model of nicotine-cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans.

Teeguarden JG, Housand CJ, Smith JN, Hinderliter PM, Gunawan R, Timchalk CA. Teeguarden JG, et al. Among authors: housand cj. Regul Toxicol Pharmacol. 2013 Feb;65(1):12-28. doi: 10.1016/j.yrtph.2012.10.007. Epub 2012 Oct 23. Regul Toxicol Pharmacol. 2013. PMID: 23099439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters